Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hervana

Hervana
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$997K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of female non-hormonal contraceptives. The company develops a sperm motility-inhibiting probiotic agent which prevents fertilization and also protects against sexually transmitted diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • Naftali 9/8
  • Jerusalem
  • Israel

+972 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hervana’s full profile, request a free trial.

Hervana Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 04-Jun-2012 $997K Completed Startup
2. Grant 01-May-2010 00000 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Hervana Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0

Hervana Executive Team (3)

Name Title Board
Seat
Contact
Info
Rachel Teitelbaum Ph.D Founder & Co-Chief Executive Officer
David Zakai Chief Operating Officer, Vice President, Business Development & Chief Business Officer

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »